Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
peng yuan kang[Author]
(16 results)?
Changes in the phenotype and function of mucosal-associated invariant T cells in neutrophilic asthma.
Int Immunopharmacol. 2022 May;106:108606. doi: 10.1016/j.intimp.2022.108606. Epub 2022 Feb 15.
Int Immunopharmacol. 2022.
PMID: 35180624
Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker.
Yang Y, Liu Q, Guo X, Yuan Q, Nian S, Kang P, Xu Z, Li L, Ye Y.
Yang Y, et al. Among authors: kang p.
J Oncol. 2022 Aug 31;2022:8115474. doi: 10.1155/2022/8115474. eCollection 2022.
J Oncol. 2022.
PMID: 36090896
Free PMC article.
Item in Clipboard
Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade.
Kang P, Liu D, Li L, Guo X, Ye Y, Li Y, Jiang Q, Lin S, Yuan Q.
Kang P, et al.
Cytokine. 2023 Mar;163:156133. doi: 10.1016/j.cyto.2023.156133. Epub 2023 Jan 30.
Cytokine. 2023.
PMID: 36724715
Item in Clipboard
Neuropilin-1 is a valuable biomarker for predicting response of advanced non-small cell lung cancer patients to hypofractionated radiotherapy and PD-1 blockade.
Kang P, Li Y, Hu Z, Lei M, Cheng J, Guo X, Zhang L, Lin S, Yuan Q.
Kang P, et al.
Int Immunopharmacol. 2022 Aug;109:108732. doi: 10.1016/j.intimp.2022.108732. Epub 2022 Apr 22.
Int Immunopharmacol. 2022.
PMID: 35468364
Item in Clipboard
Cite
Cite